China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,188 | -4,736 | -3,079 | -3,973 | -3,400 |
| Depreciation Amortization | 1,579 | 2,677 | 2,754 | 2,701 | 3,338 |
| Accounts receivable | 13,208 | -198 | -938 | -170 | -546 |
| Accounts payable and accrued liabilities | 1,116 | -303 | 570 | 505 | 83 |
| Other Working Capital | 14,870 | 1,195 | -396 | 878 | 52 |
| Other Operating Activity | -27,438 | 959 | 390 | -350 | 223 |
| Operating Cash Flow | $148 | $-406 | $-700 | $-410 | $-250 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -59 | -38 | -12 | -402 | -438 |
| Purchase Sale Intangibles | -78 | -253 | N/A | N/A | N/A |
| Other Investing Activity | -78 | -253 | 0 | 0 | 0 |
| Investing Cash Flow | $-137 | $-292 | $-12 | $-402 | $-438 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 961 | 520 | 1,563 | 594 | 10,012 |
| Debt Repayment | -1,176 | -493 | -1,490 | -2,364 | -2,888 |
| Other Financing Activity | -79 | -61 | 0 | 0 | -2,527 |
| Financing Cash Flow | $-294 | $-34 | $73 | $-1,770 | $4,598 |
| Exchange Rate Effect | 1 | -65 | 32 | -248 | -8 |
| Beginning Cash Position | 627 | 1,424 | 2,030 | 4,859 | 958 |
| End Cash Position | 345 | 627 | 1,424 | 2,030 | 4,859 |
| Net Cash Flow | $-282 | $-797 | $-606 | $-2,829 | $3,901 |
| Free Cash Flow | |||||
| Operating Cash Flow | 148 | -406 | -700 | -410 | -250 |
| Capital Expenditure | -59 | -38 | -12 | -402 | -438 |
| Free Cash Flow | 89 | -445 | -711 | -812 | -688 |